Circulation:中年血压变化影响心血管事件风险

2012-01-01 MedSci原创 MedSci原创

近日,一项研究显示中年期血压的增高或降低可以显著的影响生存期发生心脑血管疾病的风险。研究人员发现可以维持正常血压或者能降低到正常血压的人在55岁时发生心脑血管疾病生存期风险最低。相反,那些在55岁之前患有高血压的发生心脑血管疾病的生存期风险最高,该研究结果发表在《循环》杂志(Circulation)上。 研究亮点 中年期血压改变可以影响生存期心脏病和中风的风险 中年期维持或降低到正常血压

近日,一项研究显示中年期血压的增高或降低可以显著的影响生存期发生心脑血管疾病的风险。研究人员发现可以维持正常血压或者能降低到正常血压的人在55岁时发生心脑血管疾病生存期风险最低。相反,那些在55岁之前患有高血压的发生心脑血管疾病的生存期风险最高,该研究结果发表在《循环》杂志(Circulation)上。

研究亮点

中年期血压改变可以影响生存期心脏病和中风的风险

中年期维持或降低到正常血压水平能使生存期心血管病风险降到最低,然而血压增高的人风险也最高

年龄和血压改变的持续时间有助于确定个体化生存期风险并且预防心血管疾病

研究人员发现可以维持正常血压或者能降低到正常血压的人在55岁时发生心脑血管疾病生存期风险最低(发病风险率为22%-41%)。相反,那些在55岁之前患有高血压的发生心脑血管疾病的生存期风险最高(42%-69%)。

根据来自61585名病人的数据,在心血管生存期风险分担项目中,研究人员检查了中年期血压改变如何影响生存期CVD风险。预防性研究曾经考虑在一个特定的年龄单次测量。在这一研究中,将55岁作为中年期的中间点。

随访调查以14年之前的血压值作为基础血压,研究人员跟踪了血压改变直到55岁,然后继续随访患者直到发生首次心血管事件(包括心脏病和中风)死亡或者到95岁。

主要研究者Norrina艾伦博士指出,考虑血压改变可以更准确地评估心脑血管疾病的生存期风险,而且有助于我们预测个人风险从而制定个体化预防策略。中年期回避反应和高血压延期发作似乎对个体残余生存期CVD风险具有显著的影响。

研究人员还发现

在中年期患高血压的男性,70%将在85岁左右发生CVD事件

与那些血压正常的女性相比,在较中年期(平均年龄41岁)早患有高血压的女性,55岁时发生CVD风险较高(49.4%)。

一般来说在中年期,女性血压升高较多

平均年龄55岁时,49.4%的男性和47.5%的女性患有高血压

55岁及55岁以上人群总体生存期CVD风险为52.5%,女性风险为39.9%。

该研究的另一作者唐纳德M.劳埃德-琼斯提到,数据表明早期血压升高和血压随时间改变影响未来心血管疾病的风险,人们可以早期采取预防措施以减少心脏病发作或中风的机会。保持健康的饮食,结合体育锻炼和控制体重,有助于降低血压,进而降低CVD风险。(生物谷Bioon.com)

doi:10.1161/?CIRCULATIONAHA.110.002774

Impact of Blood Pressure and Blood Pressure Change During Middle Age on the Remaining Lifetime Risk for Cardiovascular Disease: The Cardiovascular Lifetime Risk Pooling Project.

Allen N,Berry JD,Lloyd-Jones DM,et al.

BACKGROUND: Prior estimates of lifetime risk (LTR) for cardiovascular disease (CVD) examined the impact of blood pressure at the index age and did not account for changes in blood pressure over time. We examined how changes in blood pressure during middle-age affect LTR for CVD, coronary heart disease (CHD) and stroke.

METHODS AND RESULTS: Data from 7 diverse US cohort studies were pooled. Remaining LTR for CVD, CHD and stroke were estimated for White and Black men and women with death free of CVD as a competing event. LTR for CVD by blood pressure (BP) strata and by changes in BP over an average of 14 years were estimated. Starting at age 55, we followed 61,585 men and women for 700,000 person-years. LTR for CVD was 52.5% (95% CI 51.3-53.7) for men and 39.9% (38.7-41.0) for women. LTR for CVD was higher for Blacks and increased with increasing BP at index age. Individuals who maintained or decreased their BP to normal levels had the lowest remaining LTR for CVD, 22-41%, as compared to individuals who had or developed hypertension by the age of 55, 42-69%; suggesting a dose-response effect for the length of time at high BP levels.

CONCLUSIONS: Individuals who experience increases or decreases in BP in middle age have associated higher and lower remaining LTR for CVD. Prevention efforts should continue to emphasize the importance of lowering BP and avoiding or delaying the incidence of hypertension in order to reduce the LTR for CVD.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1709680, encodeId=caa41e0968065, content=<a href='/topic/show?id=4cc58893ea0' target=_blank style='color:#2F92EE;'>#血压变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88937, encryptionId=4cc58893ea0, topicName=血压变化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1b531772449, createdName=ms1467340776200723, createdTime=Mon Oct 22 11:35:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643287, encodeId=0dfd164328e9b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sat Nov 17 03:35:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287590, encodeId=7600128e5900d, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Tue Jan 03 04:35:00 CST 2012, time=2012-01-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1709680, encodeId=caa41e0968065, content=<a href='/topic/show?id=4cc58893ea0' target=_blank style='color:#2F92EE;'>#血压变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88937, encryptionId=4cc58893ea0, topicName=血压变化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1b531772449, createdName=ms1467340776200723, createdTime=Mon Oct 22 11:35:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643287, encodeId=0dfd164328e9b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sat Nov 17 03:35:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287590, encodeId=7600128e5900d, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Tue Jan 03 04:35:00 CST 2012, time=2012-01-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1709680, encodeId=caa41e0968065, content=<a href='/topic/show?id=4cc58893ea0' target=_blank style='color:#2F92EE;'>#血压变化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88937, encryptionId=4cc58893ea0, topicName=血压变化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1b531772449, createdName=ms1467340776200723, createdTime=Mon Oct 22 11:35:00 CST 2012, time=2012-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643287, encodeId=0dfd164328e9b, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sat Nov 17 03:35:00 CST 2012, time=2012-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1287590, encodeId=7600128e5900d, content=<a href='/topic/show?id=3c3d51e4459' target=_blank style='color:#2F92EE;'>#心血管事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51744, encryptionId=3c3d51e4459, topicName=心血管事件风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Tue Jan 03 04:35:00 CST 2012, time=2012-01-03, status=1, ipAttribution=)]